No Plan to Sell SpaceX: Shulman

ERShares Private-Public Crossover ETF has taken in more than $470 million since Dec. 8 as investors seek exposure to SpaceX ahead of a potential IPO. EntrepreneurShares founder and CIO Joel Shulman discussed the inflows on Bloomberg's ETF IQ, highlighting strong speculative demand for pre-IPO access via the ETF. The move signals concentrated investor positioning into private-to-public crossover vehicles but is unlikely to have broad market impact.

Analysis

Demand for liquid access to late-stage private tech is creating a one-way funding channel that compresses public/private valuation spreads and concentrates risk in a handful of related securities. That dynamic tends to bid up prices of pure-play public analogs and suppliers ahead of actual IPO fundamentals, inflating implied vol and skew while creating a fragile premium that can gap when an expected listing slips or is priced conservatively.

Second-order winners are the transaction and custody intermediaries (secondaries desks, APs, OTC platforms) that capture recurring fees and margin on tight windows of supply; second-order losers are broad retail thematic vehicles and SPAC arbitrageurs who hold inventory with poor liquidity. For industrial incumbents that supply mission-critical hardware, a re-rating is possible if flows translate into multi-year contract wins, but for experiential or consumer-facing “space” equities the correlation to any one late-stage IPO is high and idiosyncratic risk dominates.

Key catalysts: an actual IPO pricing and lockup schedule (days–weeks) will likely produce a sharp “sell-the-news” repricing; macro shocks (rates, credit) or regulatory scrutiny of private valuations are multi-month to multi-year tail risks that can reverse the current bid. The immediate tactical edge is to exploit the liquidity/valuation mismatch via relative-value pairs and volatility buys rather than one-way exposure to the narrative.

Contrarian view: the market is underestimating how quickly a liquidity mismatch can force discounts on thinly traded pre-IPO exposures — a 20–40% drawdown in implied private-market marks is feasible if redemptions accelerate. Position sizing and optionality should prioritize hedged, event-based payoffs over pure directional long exposure.

Key Decisions for Investors

• Pair trade — Long RKLB (Rocket Lab) vs Short SPCE (Virgin Galactic); 6–12 month horizon. Rationale: capture operational/industrial exposure while shorting narrative-driven experiential names; target 20–30% relative outperformance with a max downside of ~20% if sector is re-rated up by a positive IPO surprise.
• Long LHX (L3Harris) 12-month buy-and-hold. Rationale: defense/aerospace suppliers can capture durable OEM orders if private-sector capex shifts to launch/satellite build-out; target 15–25% upside, set stop-loss at ~12% to limit trade to 1:2 risk/reward.
• Short ARKX (ARK Space ETF) via 3–6 month options (buy ATM puts or bear-put spread). Rationale: thematic ETF likely to give back premium on any IPO disappointment; cost-limited put spreads targeting 2:1 payoff if sector corrects 20%+.
• Vol hedge — Buy 3–6 month put spreads on SPCE (cheap liquid hedge) sized to cover 30–50% of gross long exposure to public space/launch names. Rationale: protects against a swift narrative reversal around IPO/pricing events; expect hedge to pay off on 25–40% downside scenarios.